News Focus
News Focus
Followers 68
Posts 2924
Boards Moderated 0
Alias Born 04/22/2022

Re: Investor082 post# 823426

Tuesday, 04/28/2026 9:22:18 PM

Tuesday, April 28, 2026 9:22:18 PM

Post# of 825931
Investor082,

Thanks for reposting that again, but your opinions & predictions are still just baseless rumor. 😶

LP is the largest SHAREHOLDER, so she’s not going to “pull the rug” or act against the best interests of shareholders, including herself.

LP has focused on building prospective value via NWBO’s associations with UCLA, Pittsburgh, Roswell, & King’s College. She has leveraged research funded by peer-reviewed grants & she built, developed, & acquired more assets for the company…

NWBO recently expanded its asset portfolio significantly in 2024 & 2025 with the IP licensing deal of more cell-based technology & the
acquisition of Advent.


DCVax®-L
✅ DCVax®-Direct
✅ Polarized aDC1 Platform




AI Fact-Checking


All foregoing comments relate exclusively to the topic of Northwest Biotherapeutics and its stock. Statements are made in the context of public discussion and are directed solely at the content of claims, forecasts, or interpretations presented therein. Any emphasis in tone or phrasing is used solely to highlight discrepancies, inconsistencies, unsupported conclusions, or areas where additional substantiation may be appropriate or requested in furtherance of the discussion. Nothing herein is intended as commentary on any individual participant, identity, or posting alias.
Bullish
Bullish

I am a long NWBO shareholder. Views expressed are my own, and I have no affiliation with the company.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News